SCHEMBL9303230

SCHEMBL9303230

N=C(N)Nc1ccccc1C(=O)Nc1cc(C(=N)N)cc2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
KDM4E B2RXH2 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
POLB P06746 1/20 0.49
H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 P62805 1/20 0.47
EP300 Q09472 1/20 0.47
PRMT1 Q99873 1/20 0.47
HSD17B10 Q99714 1/20 0.47
CHRNB2 P17787 1/20 0.47
CHRNB4 P30926 1/20 0.47
CHRNA3 P32297 1/20 0.47
CHRNA4 P43681 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
GAA P10253 3/20 0.47
ALDH1A1 P00352 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9303523 0.90 NPC1 (0.53) NPC1RAB9AKDM4ESMN1; SMN2POLB
SCHEMBL9303274 0.84 PLAU (0.62) NPC1RAB9AKDM4ESMN1; SMN2POLB
SCHEMBL9302624 0.84 PLAU (0.53) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL9303439 0.83 NPC1 (0.45) NPC1RAB9AKDM4ESMN1; SMN2POLB
SCHEMBL9304163 0.81 PTGES (0.54) NPC1RAB9AKDM4ECYP1A2CYP3A4
SCHEMBL9302832 0.81 RXFP1 (0.50) NPC1RAB9AKDM4ESMN1; SMN2POLB
SCHEMBL9302926 0.81 RAB9A (0.50) NPC1RAB9AKDM4ESMN1; SMN2POLB
SCHEMBL9302237 0.80 F10 (0.49) NPC1RAB9AKDM4ESMN1; SMN2POLB
SCHEMBL9303221 0.80 NPC1 (0.46) NPC1RAB9AKDM4ESMN1; SMN2POLB
SCHEMBL9303445 0.79 NPC1 (0.54) NPC1RAB9AKDM4ESMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5352704-A Antiviral agents BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-10-04 US disclosed
EP-0434432-B1 Guanidinobenzene derivatives BANYU PHARMA CO LTD (JP) 1994-05-04 EP disclosed
EP-0434432-A1 Guanidinobenzene derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1991-06-26 EP disclosed